Market Overview

Teva Pharmaceutical Industries Limited Sees FY2012 EPS $4.85-5.15 vs $5.63 Est; Sees Sales $19.50B-20.50B vs $20.75B Est

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance

 

Related Articles (TEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters